Filing Details

Accession Number:
0001144204-15-018080
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-24 16:06:18
Reporting Period:
2015-03-20
Filing Date:
2015-03-24
Accepted Time:
2015-03-24 16:06:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253886 G Patrick Enright C/O Longitude Capital Partners, Llc
800 El Camino Real, Suite 220
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-20 634,516 $2.77 13,145,097 No 4 X Indirect By LVP
Common Stock Disposition 2015-03-20 300,447 $5.85 12,844,650 No 4 S Indirect By LVP
Common Stock Acquisiton 2015-03-20 486,443 $2.77 13,331,093 No 4 X Indirect By LVP
Common Stock Disposition 2015-03-20 230,333 $5.85 13,100,760 No 4 S Indirect By LVP
Common Stock Acquisiton 2015-03-20 9,750 $2.77 182,742 No 4 X Indirect By LCA
Common Stock Disposition 2015-03-20 4,617 $5.85 178,125 No 4 S Indirect By LCA
Common Stock Acquisiton 2015-03-24 1,130,709 $2.77 14,231,469 No 4 X Indirect By LVP
Common Stock Disposition 2015-03-24 554,348 $5.65 13,677,121 No 4 S Indirect By LVP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Indirect By LVP
No 4 S Indirect By LVP
No 4 X Indirect By LVP
No 4 S Indirect By LVP
No 4 X Indirect By LCA
No 4 S Indirect By LCA
No 4 X Indirect By LVP
No 4 S Indirect By LVP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Disposition 2015-03-20 634,516 $0.00 634,516 $2.77
Common Stock Warrant (Right to Buy) Disposition 2015-03-20 486,443 $0.00 486,443 $2.77
Common Stock Warrant (Right to Buy) Disposition 2015-03-20 9,750 $0.00 9,750 $2.77
Common Stock Warrant (Right to Buy) Disposition 2015-03-24 1,130,709 $0.00 1,130,709 $2.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,130,709 2008-03-25 2015-03-24 No 4 X Indirect
0 2009-02-06 2015-03-24 No 4 X Indirect
0 2009-02-06 2015-03-24 No 4 X Indirect
0 2008-03-25 2015-03-24 No 4 X Indirect
Footnotes
  1. Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). Patrick G. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP. Mr. Enright serves on the Board of Directors of the Issuer as the nominee of LVP. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP, except to the extent of his pecuniary interest therein.
  2. On March 20, 2015, LVP exercised a warrant to purchase 634,516 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 300,447 of such shares to pay the exercise price and issuing to LVP the remaining 334,069 shares. In connection with such exercise, the Issuer also paid to LVP $5.63 in cash in lieu of a fractional share.
  3. On March 20, 2015, LVP exercised a warrant to purchase 486,443 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 230,333 of such shares to pay the exercise price and issuing to LVP the remaining 256,110 shares. In connection with such exercise, the Issuer also paid to LVP $0.94 in cash in lieu of a fractional share.
  4. Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). Patrick G. Enright is a managing member of Longitude Capital, the sole general partner of LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LCA, except to the extent of his pecuniary interest therein.
  5. On March 20, 2015, LCA exercised a warrant to purchase 9,750 shares of the Issuer's common stock for an exercise price of $2.77 per share. LCA paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 4,617 of such shares to pay the exercise price and issuing to LCA the remaining 5,133 shares. In connection with such exercise, the Issuer also paid to LCA $1.95 in cash in lieu of a fractional share.
  6. On March 24, 2015, LVP exercised a warrant to purchase 1,130,709 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 554,348 of such shares to pay the exercise price and issuing to LVP the remaining 576,361 shares. In connection with such exercise, the Issuer also paid to LVP $2.27 in cash in lieu of a fractional share.